Skeletal muscle mitochondrial function in polycystic ovarian syndrome

European Journal of Endocrinology

Volumn 165, Issue 4, 2011, Pages 631-637

  Rabøl, Rasmus ^a,b   Svendsen, Pernille F ^b   Skovbro, Mette ^a   Boushel, Robert ^a   Schjerling, Peter ^a,c   Nilas, Lisbeth ^b   Madsbad, Sten ^b   Dela, Flemming ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; GLUCOSE; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE);

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA CONTENT; DNA DETERMINATION; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MITOCHONDRIAL RESPIRATION; MUSCLE BIOPSY; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIROMETRY; SKELETAL MUSCLE; WESTERN BLOTTING;

ABSORPTIOMETRY, PHOTON; ADULT; AMENORRHEA; BODY COMPOSITION; BODY MASS INDEX; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; MITOCHONDRIA, MUSCLE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; OBESITY; OLIGOMENORRHEA; OXYGEN CONSUMPTION; POLYCYSTIC OVARY SYNDROME;

EID: 80053525232     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0419     Document Type: Article

References (22)

1. Ehrmann DA. Polycystic ovary syndrome. New England Journal of Medicine 2005 352 1223-1236. (doi:10.1056/NEJMra041536)
2. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES & Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. Journal of Clinical Endocrinology and Metabolism 2004 89 2745-2749. (doi:10.1210/jc.2003-032046)
3. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 1997 18 774-800. (doi:10.1210/er.18.6.774)
4. Petersen KF & Shulman GI. Etiology of insulin resistance. American Journal of Medicine 2006 119 S10-S16. (doi:10.1016/j.amjmed.2006.01.009)
5. Skov V, Glintborg D, Knudsen S, Jensen T, Kruse TA, Tan Q, Brusgaard K, Beck-Nielsen H & Hojlund K. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome. Diabetes 2007 56 2349-2355. (doi:10.2337/db07-0275)
6. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D & Groop LC. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genetics 2003 34 267-273. (doi:10.1038/ng1180)
7. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR & Mandarino LJ. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. PNAS 2003 100 8466-8471. (doi:10.1073/pnas.1032913100)
8. Victor VM, Rocha M, Banuls C, Sanchez-Serrano M, Sola E, Gomez M & Hernandez-Mijares A. Mitochondrial complex I impairment in leukocytes from polycystic ovary syndrome patients with insulin resistance. Journal of Clinical Endocrinology and Metabolism 2009 94 3505-3512. (doi:10.1210/jc.2009-0466)
9. Gnaiger E. Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology. International Journal of Biochemistry & Cell Biology 2009 41 1837-1845. (doi:10.1016/j.biocel.2009. 03.013)
10. Svendsen PF, Nilas L, Norgaard K, Jensen JE & Madsbad S. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. Human Reproduction 2008 23 2113-2121. (doi:10.1093/humrep/den211)
11. Svendsen PF, Madsbad S & Nilas L. The insulin-resistant phenotype of polycystic ovary syndrome. Fertility and Sterility 2010 94 1052-1058. (doi:10.1016/j.fertnstert.2009.04.008)
12. Rabol R, Svendsen PF, Skovbro M, Boushel R, Haugaard SB, Schjerling P, Schrauwen P, Hesselink MK, Nilas L, Madsbad S & Dela F. Reduced skeletal muscle mitochondrial respiration and improved glucose metabolism in nondiabetic obese women during a very low calorie dietary intervention leading to rapid weight loss. Metabolism 2009 58 1145-1152. (doi:10.1016/j.metabol.2009.03.014)
13. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsoe R & Dela F. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 2007 50 790-796. (doi:10.1007/s00125-007-0594-3)
14. Larsen S, Ara I, Rabol R, Andersen JL, Boushel R, Dela F & Helge JW. Are substrate use during exercise and mitochondrial respiratory capacity decreased in arm and leg muscle in type 2 diabetes? Diabetologia 2009 52 1400-1408. (doi:10.1007/s00125-009-1353-4)
15. Rabol R, Hojberg PM, Almdal T, Boushel R, Haugaard SB, Madsbad S & Dela F. Effect of hyperglycemia on mitochondrial respiration in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2009 94 1372-1378. (doi:10.1210/jc.2008-1475)
16. Rabol R, Boushel R, Almdal T, Hansen CN, Ploug T, Haugaard SB, Prats C, Madsbad S & Dela F. Opposite effects of pioglitazone and rosiglitazone on mitochondrial respiration in skeletal muscle of patients with type 2 diabetes. Diabetes, Obesity & Metabolism 2010 12 806-814. (doi:10.1111/j.1463-1326. 2010.01237.x)
17. Morino K, Petersen KF, Dufour S, Befroy D, Frattini J, Shatzkes N, Neschen S, White MF, Bilz S, Sono S, Pypaert M & Shulman GI. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. Journal of Clinical Investigation 2005 115 3587-3593. (doi:10.1172/JCI25151)
18. Kelley DE, He J, Menshikova EV & Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002 51 2944-2950. (doi:10.2337/diabetes.51.10.2944)
19. Holloszy JO. Skeletal muscle "mitochondrial deficiency" does not mediate insulin resistance. American Journal of Clinical Nutrition 2009 89 463S-466S. (doi:10.3945/ajcn.2008.26717C)
20. Rabol R, Boushel R & Dela F. Mitochondrial oxidative function and type 2 diabetes. Applied Physiology, Nutrition, and Metabolism 2006 31 675-683. (doi:10.1139/h06-071)
21. Shulman GI. Cellular mechanisms of insulin resistance. Journal of Clinical Investigation 2000 106 171-176. (doi:10.1172/JCI10583)
22. Perseghin G, Scifo P, Danna M, Battezzati A, Benedini S, Meneghini E, Del Maschio A & Luzi L. Normal insulin sensitivity and IMCL content in overweight humans are associated with higher fasting lipid oxidation. American Journal of Physiology. Endocrinology and Metabolism 2002 283 E556-E564. (doi:10.1152/ajpendo.00127.2002)